Women's Malignancies Branch

Stanley Lipkowitz, M.D., Ph.D.

lipkowis@mail.nih.gov

Patricia S. Steeg, Ph.D.

steegp@mail.nih.gov

Prev

About
Clinical Trials
PI & Key Staff
Job Vacancies
News
Contact

Next

About

The Women’s Malignancies Branch (WMB) is committed to developing new treatments for patients with breast and gynecologic malignancies in order to improve the outcomes for patients with these diseases. The members of WMB conduct basic and translational research and integrate laboratory research findings into hypothesis-driven clinical trials for these malignancies. We encourage patients to explore our website and contact us for questions related to our research and clinical trial opportunities.

Clinical Trials

Open - Not yet Recruiting

Randomized Phase II Trial of Durvalumab (D) plus Olaparib (O) and Cediranib (C: DOC) Compared to OC or DC or Chemotherapy in Platinum-Resistant Recurrent Ovarian Cancer with Prior Bevacizumab

Protocol ID
NCI000484

Investigator

Jung-Min Lee, M.D.

Referral Contacts

Erin Villanueva

240.760.6131
Open - Recruiting

Incidental detection of maternal neoplasia through non-invasive cell-free DNA analysis (IDENTIFY), a natural history study

Protocol ID
NCI-19-C-0132

Investigator

Christina M. Annunziata, M.D., Ph.D.

Referral Contacts

Amy Turriff

301.402.5421
Open - Recruiting

Phase 1 with Expansion Cohorts in a Study of NEO-201 In Adults with Chemo-resistant Solid Tumors

Protocol ID
NCI-18-C-0147

Investigator

Christina M. Annunziata, M.D., Ph.D.

Referral Contacts

Irene Ekwede

240-760-6126
Open - Recruiting

Phase I/II Study of the Anti-Programmed Death Ligand-1 Antibody Durvalumab (MEDI4736) in Combination with Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Cancers

Protocol ID
NCI-15-C-0145

Investigator

Jung-Min Lee, M.D.

Referral Contacts

Helen Owens

301-435-5612

Irene Ekwede

301-435-4859

Linda Sciuto

301-451-9707

Melissa Walker

301-827-3456

Nicole Houston

301-443-6431

PI & Key Staff

Job Vacancies

There are no open positions at this time. Check back again later, or take a look at CCR's Careers page.

News

**Stanley Lipkowitz, M.D., Ph.D. and Yoshimi Greer, M.D., Ph.D. discuss about the paper "ONC201 kills breast cancer cells in vitro by targeting mitochondria" in a video interview**

Impact Journals, LLC. Aug.10, 2020

Youtube link - https://youtu.be/55awJT-utxk

Soundcloud podcast - https://soundcloud.com/oncotarget/interview-with-the-national-institutes-of-healths-dr-stanley-lipkowitz-dr-yoshimi-endo-greer

Full text - https://www.oncotarget.com/article/24862/text/

Press release - https://www.oncotarget.com/news/pr/onc201-kills-breast-cancer-cells-in-vitro-by-targeting-mitochondria

Contact

Contact Info

Center for Cancer Research National Cancer Institute

Building 10, Room 4B54
Bethesda, MD 20892-1361
240-858-3007
240-541-4547

Secretary

Josselyn White

josselyn.white@nih.gov